摘要: A highly regulated network of protein-protein interactions is now known to be the central underlying theme in controlling apoptosis. Understanding chemical basis these a major key understanding mechanisms this diverse pathway, while outcome offers remarkable benefits treatment many pathological diseases. It undisputed that Bcl-2 proteins regulate mitochondrial apoptotic however considerable controversy exists as how they do at molecular level. If desire apotosis various conditions or even exploit apoptosis pathway our advantage we need firstly understand precise function all pro- and anti-apoptotic proteins. vital determine which are important cell lines by pathways act carry out their before can target them. However, it clear family still for control has been shown point variety cellular damage signals multitude types.
springer.com
springerlink.com参考文章(125)
Chittenden T, Avery Bj, Subramanian T, Gallo Gj, Houghton Ab, Boyd Jm, Ebb Rg, Malstrom S, Elangovan B, Lutz Rj, Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene. ,vol. 11, pp. 1921- 1928 ,(1995)
Shaun P. Holmgreen, Suzanne Cory, Elizabeth Baker, Leonie Gibson, Jerry M. Adams, Nancy A. Jenkins, Neal G. Copeland, Grant R. Sutherland, David C.S. Huang, Ora Bernard, bcl-w, a novel member of the bcl-2 family, promotes cell survival. Oncogene. ,vol. 13, pp. 665- 675 ,(1996)
Tetsuo Fujita, Satoshi Terada, Katsuyuki Fukuoka, Atsushi Kitayama, Hiroshi Ueda, Eiji Suzuki, Reinforcing apoptosis-resistance of COS and myeloma cells by transfecting with bcl-2 gene Cytotechnology. ,vol. 25, pp. 25- 33 ,(1997) , 10.1023/A:1007935026770
Maryla Krajewska, Ahmed Shabaik, Stanislaw Krajewski, Hong Gang Wang, John C. Reed, Toshiyuki Miyashita, Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. American Journal of Pathology. ,vol. 145, pp. 1323- 1336 ,(1994)
Goluboff Et, Buttyan R, Dorai T, Olsson Ca, Development of a hammerhead ribozyme against BCL-2. II. Ribozyme treatment sensitizes hormone-resistant prostate cancer cells to apoptotic agents. Anticancer Research. ,vol. 17, pp. 3307- 3312 ,(1997)
D. Fassnacht, S. Rössing, R. P. Singh, M. Al-Rubeai, R. Pörtner, Influence of bcl-2 on antibody productivity in high cell density perfusion cultures of hybridoma. Cytotechnology. ,vol. 30, pp. 95- 106 ,(1999) , 10.1023/A:1008055702079
E. M. Bruckheimer, S. H. Cho, M. Sarkiss, J. Herrmann, T. J. McDonnell, The Bcl-2 gene family and apoptosis Apoptosis. ,vol. 62, pp. 75- 105 ,(1998) , 10.1007/BFB0102306
A. Ishaque, M. Al-Rubeai, Role of vitamins in determining apoptosis and extent of suppression by bcl-2 during hybridoma cell culture. Apoptosis. ,vol. 7, pp. 231- 239 ,(2002) , 10.1023/A:1015343616059
Andy J. Minn, Rachel E. Swain, Averil Ma, Craig B. Thompson, Recent progress on the regulation of apoptosis by Bcl-2 family members. Advances in Immunology. ,vol. 70, pp. 245- 279 ,(1998) , 10.1016/S0065-2776(08)60388-0
J. E. Reynolds, A. Eastman, R. W. Craig, J. D. Jenkinson, Liping Qian, Ping Zhou, Tao Yang, Mcl-1, a Member of the Bcl-2 Family, Delays Apoptosis Induced by c-Myc Overexpression in Chinese Hamster Ovary Cells Cancer Research. ,vol. 54, pp. 6348- 6352 ,(1994)